NCT02457793 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- One participant was assigned to receive intermittent cobimetinib 80 milligrams (mg) + GDC 0994 200 mg) and did receive study drug. However, the participant diary was not returned, and the site was unable to document study dose administration.
- id
- FG000
- title
- Not Assigned
- description
- Concurrent or intermittent dosing of cobimetinib 20 mg, concurrent with GDC-0994 200 mg for 21 consecutive days, followed by 7 days off.
- id
- FG001
- title
- COB 20 mg + GDC 200 mg
- description
- Concurrent or intermittent dosing of cobimetinib 40 mg, concurrent with GDC-0994 200 mg for 21 consecutive days, followed by 7 days off.
- id
- FG002
- title
- COB 40 mg + GDC 200 mg
- description
- Concurrent or intermittent dosing of cobimetinib 80 mg, concurrent with GDC-0994 200 mg for 21 consecutive days, followed by 7 days off.
- id
- FG003
- title
- COB 80 mg + GDC 200 mg
- description
- Concurrent or intermittent dosing of cobimetinib 80 mg, concurrent with GDC-0994 400 mg for 21 consecutive days, followed by 7 days off.
- id
- FG004
- title
- COB 80 mg + GDC 400 mg
- description
- Concurrent or intermittent dosing of cobimetinib 100 mg, concurrent with GDC-0994 200 mg for 21 consecutive days, followed by 7 days off.
- id
- FG005
- title
- COB 100 mg + GDC 200 mg
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 1
- group Id
- FG004
- num Subjects
- 1
- group Id
- FG005
- num Subjects
- 1
- type
- Reason not specified
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 4
- group Id
- FG002
- num Subjects
- 2
- group Id
- FG003
- num Subjects
- 2
- group Id
- FG004
- num Subjects
- 2
- group Id
- FG005
- num Subjects
- 2
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 1
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- type
- Adverse Event
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 1
- group Id
- FG003
- num Subjects
- 1
- group Id
- FG004
- num Subjects
- 1
- group Id
- FG005
- num Subjects
- 3
- type
- Physician Decision
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 5
- group Id
- FG002
- num Subjects
- 3
- group Id
- FG003
- num Subjects
- 5
- group Id
- FG004
- num Subjects
- 4
- group Id
- FG005
- num Subjects
- 6
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 1
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 4
- group Id
- FG002
- num Subjects
- 3
- group Id
- FG003
- num Subjects
- 5
- group Id
- FG004
- num Subjects
- 4
- group Id
- FG005
- num Subjects
- 6
- type
- NOT COMPLETED
- title
- Overall Study
Complete source fields
- groups
- description
- One participant was assigned to receive intermittent cobimetinib 80 milligrams (mg) + GDC 0994 200 mg) and did receive study drug. However, the participant diary was not returned, and the site was unable to document study dose administration.
- id
- FG000
- title
- Not Assigned
- description
- Concurrent or intermittent dosing of cobimetinib 20 mg, concurrent with GDC-0994 200 mg for 21 consecutive days, followed by 7 days off.
- id
- FG001
- title
- COB 20 mg + GDC 200 mg
- description
- Concurrent or intermittent dosing of cobimetinib 40 mg, concurrent with GDC-0994 200 mg for 21 consecutive days, followed by 7 days off.
- id
- FG002
- title
- COB 40 mg + GDC 200 mg
- description
- Concurrent or intermittent dosing of cobimetinib 80 mg, concurrent with GDC-0994 200 mg for 21 consecutive days, followed by 7 days off.
- id
- FG003
- title
- COB 80 mg + GDC 200 mg
- description
- Concurrent or intermittent dosing of cobimetinib 80 mg, concurrent with GDC-0994 400 mg for 21 consecutive days, followed by 7 days off.
- id
- FG004
- title
- COB 80 mg + GDC 400 mg
- description
- Concurrent or intermittent dosing of cobimetinib 100 mg, concurrent with GDC-0994 200 mg for 21 consecutive days, followed by 7 days off.
- id
- FG005
- title
- COB 100 mg + GDC 200 mg
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 1
- group Id
- FG004
- num Subjects
- 1
- group Id
- FG005
- num Subjects
- 1
- type
- Reason not specified
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 4
- group Id
- FG002
- num Subjects
- 2
- group Id
- FG003
- num Subjects
- 2
- group Id
- FG004
- num Subjects
- 2
- group Id
- FG005
- num Subjects
- 2
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 1
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- type
- Adverse Event
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 1
- group Id
- FG003
- num Subjects
- 1
- group Id
- FG004
- num Subjects
- 1
- group Id
- FG005
- num Subjects
- 3
- type
- Physician Decision
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 5
- group Id
- FG002
- num Subjects
- 3
- group Id
- FG003
- num Subjects
- 5
- group Id
- FG004
- num Subjects
- 4
- group Id
- FG005
- num Subjects
- 6
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 1
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 4
- group Id
- FG002
- num Subjects
- 3
- group Id
- FG003
- num Subjects
- 5
- group Id
- FG004
- num Subjects
- 4
- group Id
- FG005
- num Subjects
- 6
- type
- NOT COMPLETED
- title
- Overall Study
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle